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Abstract
Background/Aims: Retinoid receptors and retinoic acid were reported to be down-regulated 
in pancreatic duct adenocarcinoma (PDAC) compared to normal pancreas. Yet the mechanism 
of the down-regulation of retinoid receptors is not well defined. The aim of this study was to 
find out whether selected dysregulated miRNAs in PDAC are responsible for the decreased 
level of retinoid receptors. Methods: Bioinformatics, real-time PCR, western blot analysis as 
well as molecular manipulation with miRNA in cells of PDAC were carried out. Results: We first 
performed bioinformatics research to identify conserved target sequences for deregulated 
miRNAs within the 3’UTR region of retinoid receptor mRNA. This research revealed binding 
sites for miR-138, -27a, -27b, -206, -613, -9-5p, -27a/b-3p and -27a. Next, we investigated the 
expression of selected retinoid receptors and miRNAs in PDAC cell lines and in the Human 
Pancreatic Duct Epithelial (HPDE) cell line. Further, we investigated the effects of modifying 
expression levels of selected miRNAs using miRNA inhibitors or mimics. We demonstrated 
that none of these miRNAs can target the selected retinoid receptors in vitro. Conclusions: 
miR-27a, miR-27b, miR-9, miR10a and miR-10b were up-regulated in PDAC cells compared to 
HPDE cells. The up-regulation of these miRNAs was not responsible for the down-regulation 
of RARα, RARβ, RXRα and RXRβ in PDAC cells.
IntroductionGene expression in benign and malignant cells can be regulated on various levels, such 
as epigenetic regulation (e.g. histone modifications, DNA methylation), transcriptional 
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control (e.g. promoter regulation by transcription factors) or translational control by 
non-coding RNAs. miRNAs are small non-coding endogenous RNAs that regulate multiple 
biological processes by mechanisms that are still not fully understood [1]. These regulatory 
elements are first transcribed and then processed by Dicer and Drosha complexes into 
21–23nt mature miRNAs [2]. The miRNA is incorporated into the RNA-induced silencing 
complex (RISC) containing Dicer and many other associated proteins including members of 
the Argonaute (Ago) protein family [3]. RISC regulates posttranscriptional mRNA expression 
(i.e. translation suppression) typically by binding to the 3’ untranslated region (3’-UTR) 
of the complementary mRNA sequence, preventing the recognition of cap by eIF4E and 
subsequent binding of translational factors [4]. Therefore, there is some evidence proving 
that the translation activation by miRNAs is regulated through direct or indirect ways [5]. 
3’UTR is not a unique target sequence for miRNAs. It has been shown that miRNAs also 
efficiently bind to the 5’UTR [6, 7] leading to activation [8-10] or repression [11, 12] of 
translation. However the precise mechanism by which miRNA binds to the 5’UTR is still to be deciphered.
Retinoic acid, the metabolite of vitamin A, is important for growth and differentiation 
of both healthy and cancerous cells. All-trans retinoic acid (ATRA), the major physiologically 
active form of vitamin A, regulates the expression of many genes [13]. Physiological effects 
of retinoid are mainly mediated by two families of nuclear receptors: the retinoic acid 
receptor (RAR) and the retinoid X receptor (RXR). RAR and RXR are both ligand-dependent 
transcription factors, which belong to the nuclear hormone receptor superfamily. The RAR 
and RXR family comprise several isotypes: RARα, RARβ, RARγ and RXRα RXRβ, RXRγ [13].
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers in the world. 
At present, only multimodal treatment including surgical resection can prolong survival of 
patients with this disease [14]. The reasons for this poor prognosis are early dissemination, 
lack of early specific symptoms and late diagnosis [15]. Additionally, PDAC is highly resistant 
to chemo- and targeted therapy, and withstands immunotherapy [16]. Therefore, new 
therapeutic approaches against PDAC are urgently needed. It has been shown that different 
miRNA promote growth and proliferation of PDAC cells [17-20] and predict poor clinical 
outcome of patients with PDAC [21].
Recently, ATRA and its derivatives have been reported to inhibit proliferation and 
migration of various cancer types including PDAC [22, 23]. Our previous studies showed 
that the concentration of ATRA and its derivatives as well as retinoid receptor expression 
are reduced in PDAC cancer tissues compared to normal pancreatic tissue [24, 25]. More 
importantly, the reduced expression of retinoid receptors correlates with the expression of 
markers of epithelial to mesenchymal transition and stemness of PDAC cells [24]. Besides, 
the expression of RARA and RXRB is found to be associated with a better overall survival in 
PDAC patients. Accordingly, the reduced level of retinoids and their receptors is an important 
feature of PDAC [24]. However, the mechanism of the down-regulation of retinoid receptors 
is not well defined.
The present study aimed to identify novel oncogenic-suppressive miRNAs as the 
regulators of retinoid receptors in PDAC.
Materials and Methods
Materials
Ampicillin, chloroform, isopropyl alcohol, ethanol, 0.4% trypan blue solution, EDTA, TEMED, 
ammonium persulfate and DMSO were purchased from Sigma (Darmstadt, Germany). Agarose was obtained 
from Gibco BRL (Idstein, Germany). Odyssey® Blocking Buffer was purchased from LI-COR (Lincoln, NE, 
USA). Kits: HiperFect transfection, RNeasy Mini, miScript II RT, miScript SYBR Green PCR, QuantiTect Reverse 
Transcription, QuantiTect SYBR Green PCR QuantiTect Primer Assays, miScript Primer Assays and QIAzol 
Lysis Reagent were from Qiagen (Hilden, Germany). Anti-RAR and anti-RXR antibodies were obtained from 
SantaCruz (Dallas, TX, USA). Anti-MET antibody was from Sigma (Darmstadt, Germany). IRDye® 680LT 
Cell Physiol Biochem 2017;44:644-656
DOI: 10.1159/000485276
Published online: November 23, 2017 646
Cellular Physiology 
and Biochemistry
© 2017 The Author(s). Published by S. Karger AG, Basel
www.karger.com/cpb
Yin et al.: Mirna and Retinoid Receptors in PDAC
Goat anti-Mouse, IRDye® 800CW 
Donkey anti-Rabbit, IRDye® 
680CW Goat anti-Rabbit and 
IRDye® 800CW Donkey anti-
Mouse antibodies were purchased 
from LI-COR (Lincoln, NE, USA). All 
miRNA products were purchased 
from Qiagen (Hilden, Germany). 
miRNA products and primers used 
are listed in the Table 1.
Cell lines
Human PDAC cell lines: Mia-
PaCa-2 and Panc-1 derived from 
primary mesenchymal tumors and 
BxPc-3 and DanG derived from pri-
mary epithelial tumors were cho-
sen for experiments. All cell lines 
were obtained from ATCC (Manas-
sas, VA, USA). PDAC cells were 
maintained as a monolayer. Prior 
to passaging, trypsin and media were warmed up in a 37°C water bath. Cells were cultured in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum and 1% penicillin/strepto-
mycin and incubated at 37°C in a humidified atmosphere of 5% CO2/95% air. Cells were passaged once or 
twice a week when a confluence of 80% was reached. Normal HPDEcells (kindly provided by Dr. Kong Bo, 
Technical University Munich, Germany) were maintained in Keratinocyte Basal Medium with supplements 
(Lonza, Clonetics KBM, Basel, Switzerland). The flask was incubated at 37°C in a humidified atmosphere 
of 5% CO2/95% air. Culture medium was replaced every two to three days. Cells were passaged when a 
confluence of 80% is reached. All cells were routinely checked for mycoplasma in conditioned cell medium 
using PCR according to internal SOPs and authenticated commercially by IDEX BioResearch (Ludwigsburg, 
Germany).
Total RNA and miRNA isolation from cultivated cells
Total RNA from cells was isolated using RNeasy Mini Kit following the manufacturer’s instruction 
and described elsewhere [26]. RNA was quantified using a GeneQuant pro spectrophotometer (Eppendorf, 
Hamburg, Germany). The quality of isolated mRNA was evaluated by the A260/A280 value. To assess of 
RNA quality, the samples of total RNA were diluted 1:50, applied on the RNA 6000 Nano LabChip (Agilent 
Technologies, Palo Alto, CA) and analyzed with the Agilent Bioanalyzer 2100 (Aglient Technologies, Palo 
Alto, CA). All samples had RNA Integrity Numbers between 9.5 and 10.
Total miRNA from cells was isolated using QIAzol (Qiagen, Hilden, Germany) following the 
manufacturer’s instruction (miRNeasy Mini kit, Qiagen, Hilden, Germany). In brief, cells were trypsinized at 
37°C, collected and centrifuged at 300 × g for 5 minutes. The cell pellet was then washed with cold 1× PBS 3 
times. Cells were then pelleted in a 1.5ml Eppendorf tube. By adding 700 µl QIAzol lysis reagent, cells were 
lysed after incubation at room temperature for 5 minutes. Then 140 µl chloroform was added and the tube 
was shaken vigorously for 15 seconds. After incubation at room temperature for 3 minutes, the tube was 
centrifuged at 8000 × g at 4°C for 15 min. The upper aqueous phase which contains miRNA was transferred 
into a new collection tube. Then 1.5 volumes of 100% ethanol was added and well mixed, before loading onto 
a RNeasy Mini spin column in a 2 ml collection tube for centrifugation at 8000 × g (RT, 1 min). The RNeasy 
Mini spin column which contains miRNAs was then washed with 700 µl RWT Buffer (included in the Qiagen 
kit) once and 500 µl RPE Buffer (included in the Qiagen kit) twice. 30-50µl RNase-free water was then added 
directly onto the RNeasy Mini spin column membrane and miRNAs were obtained by centrifugation at 8000 
× g for 2min. RNA was quantified using a spectrophotometer. The quality of isolated miRNA was evaluated 
by the A260/A280 value. To determine the content of miRNA, each sample was diluted 1:50, applied on the 
Small RNA Nano LabChip (Agilent Technologies, Palo Alto, CA) and analyzed with the Agilent Bioanalyzer 
2100 (Agilent Technologies, Palo Alto, CA). The ratio miRNA to small RNA was in the range 1-7%.
Table 1. miRNAs products and primers
 
miRNA mimic or inhibitors        Sequence (5’-3’) Syn-hsa-miR-9-5p miScript miRNA Mimic 5'UCUUUGGUUAUCUAGCUGUAUGA Syn-hsa-miR-27a-3p miScript miRNA Mimic 5'UUCACAGUGGCUAAGUUCCGC Syn-hsa-miR-27a-5p miScript miRNA Mimic 5'AGGGCUUAGCUGCUUGUGAGCA Syn-hsa-miR-27b-3p miScript miRNA Mimic 5'UUCACAGUGGCUAAGUUCUGC Syn-hsa-miR-27b-5p miScript miRNA Mimic 5'AGAGCUUAGCUGAUUGGUGAAC Anti-hsa-miR-9-5p miScript miRNA Inhibitor 5'UCUUUGGUUAUCUAGCUGUAUGA Anti-hsa-miR-27a-3p miScript miRNA Inhibitor 5'UUCACAGUGGCUAAGUUCCGC Anti-hsa-miR-27a-5p miScript miRNA Inhibitor 5'AGGGCUUAGCUGCUUGUGAGCA Anti-hsa-miR-27b-3p miScript miRNA Inhibitor 5'UUCACAGUGGCUAAGUUCUGC Anti-hsa-miR-27b-5p miScript miRNA Inhibitor 5'AGAGCUUAGCUGAUUGGUGAAC miRNA negative control Oligos  Hs_miR-9_1 miScript Primer Assay  Hs_miR-27a_1 miScript Primer Assay  Hs_miR-27b_2 miScript Primer Assay  Hs_miR-138_1 miScript Primer Assay  Hs_miR-206_1 miScript Primer Assay  Hs_miR-613_1 miScript Primer Assay  Hs_RARA_1_SG QuantiTect Primer Assay (QT00095865)  Hs_RARB_1_SG QuantiTect Primer Assay (QT00062741)  Hs_RARG_1_SG QuantiTect Primer Assay (QT00000987)  Hs_RXRA_1_SG QuantiTect Primer Assay (QT00005726)  Hs_RXRB_1_SG QuantiTect Primer Assay (QT00061117)  Hs_RXRG_1_SG QuantiTect Primer Assay (QT00007238)  
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Real time PCR analysis of mature miRNAs
Generation of the first strand cDNA from miRNA was done using miScript II RT Kit (Qiagen, Hilden, 
Germany). For this purpose, an equal amount of miRNA (500 ng) from each miRNA sample (in a final volume 
of 20 µl containing universal primer) was added into each reaction at the last step. The miRNA was placed 
on ice and the reverse transcription reaction was set up by mixing the following components from the kit: 
4 µL of 5x miScript HiSpec Buffer, 2 µL of 10x Nucleics Mix, 2 µL of miScript Reverse Transcriptase Mix, 
variable volume of RNA template as well as RNase-free water. The end volume of each sample was 20 µL. 
The reagents were gently mixed and briefly centrifuged. Reverse transcription was carried out by incubation 
at 37°C for 60 minutes with the reaction terminated by incubation at 95°C for 5 minutes. After the reaction, 
each tube was diluted with 200 µL RNase-free water for later use in RT-PCR.
Expression of mature miRNAs was determined by miScript miRNA PCR Array (Qiagen, Hilden, 
Germany). For this purpose, 1µl cDNA was used per 25 µl reaction mixture containing 12.5 µl of 2x QuantiTect 
SYBR Green PCR Master Mix, 2.5 µl of 10x miScript Universal Primer, 2.5 µl of 10x miScript Primer Assay 
and variable volume of RNase-free Water in a 96-well plate. The 96-well plate was briefly centrifuged for 1 
minute to remove any bubbles. The reaction was then carried out for 40 cycles in StepOne™ Real-Time PCR 
System (Thermo Fisher, Darmstadt, Germany). The program included the following steps: 15 min initial 
activation at 95°C, 15 s denaturation at 94°C, 30 s annealing at 55°C and finally 30 s extension at 70°C. U6-
snRNA was used as a house-keeping control for normalization. 2-ΔΔCt method was used to calculate the fold 
change of miRNA expression using the equation 2-ΔΔCt=2-[(Ct gene of interest – Ct internal control)sample A – (Ct gene of interest – Ct internal 
control)sample B] as described elsewhere [27], where internal control refers to the house-keeping control, sample 
A was a PDAC cell line and sample B was the HPDE cell line.
SYBR Green quantitative PCR for retinoid receptor
Genomic DNA was eliminated from the RNA samples before initiating reverse transcription using the 
QuantiTect Reverse Transcription Kit (Qiagen, Hilden, Germany) with 500 ng of RNA from each sample. The 
reaction mixes for genomic DNA elimination (total volume of 14 µl) included 2 µl of 7x gDNA Wipeout Buffer 
and variable volume of Template RNA and RNase-free water. The reaction tubes were put directly on ice 
after incubation for 2 min at 42°C. After that, 6 µl of reverse-transcription master mix (1 µl of Quantiscript 
Reverse Transcriptase, 4 µl of 5x Quantiscript RT Buffer and 1 µl of RT primer mix) was prepared per sample 
on ice.  To each reverse transcription master mix tube, 14 µl of Template RNA after genomic DNA elimination 
reaction was added. In a PCR machine, reverse transcription was carried out for 15 min at 42°C and then 
Quantiscript Reverse Transcriptase was inactivated after 3 min at 95°C.
Expression of the retinoid receptor was determined by QuantiFast SYBR Green PCR kit (Qiagen, 
Hilden, Germany) following the manufacturer’s instruction and described elsewhere [24]. Briefly, 1 µl of 
cDNA synthesized before was added to reaction mix in 96-well plate. The reaction mixture consisted of the 
following components: 12.5 μl 2x QuantiFast SYBR Green PCR Master Mix, 2.5 μl 10 x QuantiTect Primers and 9 μl RNAse-free water. The 96-well plate was briefly centrifuged for 1 minute to remove any bubbles. 
The cycling program was carried out in a StepOne™ Real-Time PCR System (Thermo Fisher, Darmstadt, 
Germany) with the following parameters: 5 min PCR initial activation step at 95°C followed by 40 two-
step cycles of 10 s denaturation at 95ºC and 30 s combined annealing/ extension at 60ºC. GAPDH mRNA 
was used as a house-keeping gene for normalization. 2-ΔΔCt method was used to calculate the fold change of retinoid gene expression as described above.
Transfection of miRNAs
We used HiPerFect Transfection Reagent (Qiagen, Hilden, Germany) to transfect miRNAs into 
pancreatic cancer cells. Transfection was done following manufacturer’s manual. The initial step was to 
determine optimal miRNA transfection conditions for different cells. Briefly, 1 × 105 cells were suspended in 
0.5 ml of growth medium and seeded into one well of a 24-well plate. Then appropriate amounts of miRNA 
and HiperFect Transfection Reagent were added into 100 µl culture medium without serum. The mixture 
was vortexed and incubated for 5 to10 min at room temperature to allow the formation of transfection 
complexes. Transfection was achieved by adding the mixture dropwise onto the cells in a well. The plate 
was gently swirled and incubated under normal growth condition (5% CO2, 37°C, 90% humidity) for 48 
to 72 h. After the incubation for 48 to 72 hours, cells were collected and miRNAs were isolated with the 
protocol as described before. The level of target miRNA in transfected cells was determined by RT-PCR and 
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compared with non-transfected cells. The same protocol was used for transfection of miRNA mimics and 
miRNA inhibitors.
Western blot analysis
Western blotting was performed as described elsewhere [26]. Briefly, cells grown in a 24 well-plate 
were washed with cold phosphate-buffered saline (PBS buffer) three times and lysed in RIPA extraction 
buffer (150 mM sodium chloride, 1% NP-40 or Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS (sodium 
dodecyl sulfate) and 50mM Tris at pH 8.0) on ice for 15 min. The lysates were centrifuged at 14, 000 rpm 
for 20 min and the supernatant containing the total cell extract was stored at -80°C until used. The extracted 
protein was quantified using the BCA Protein assay kit (Thermo Fisher, Darmstadt, Germany). The proteins 
resolved by SDS-PAGE were transferred onto a PVDF membrane by semi-dry electrophoretic transfer. The 
membrane was first wetted in 100% methanol for 5 seconds and then equilibrated in transfer buffer. The 
blot was assembled on a semi-dry blotting apparatus from anode to cathode as follow: 2 Whatman papers 
soaked in transfer buffer, PVDF membrane, gel and finally 2 Whatman papers. Transfer of proteins was done 
for 1 hour by applying 1.8V per cm square of the blot. The membrane was then blocked for 1 hour at room 
temperature in TBS containing 0.1% Tween 20 and 5% BSA. The membrane was then incubated overnight 
with the primary antibody in blocking solution. Following three 10-min washes with 0.1% Tween 20 in TBS 
(TBST) the blot was incubated for 1 hour at room temperature with the fluorescence-conjugated secondary 
antibody diluted in Odyssey® Blocking Buffer (LI-COR, Lincoln, NE, USA) for 1 h at room temperature in 
the dark. The membrane was then washed 3 times at 10 min intervals with TBST buffer. Finally, the protein 
band was visualized in the Odyssey Reader machine (LI-COR, Lincoln, NE, USA). Densitometric values of the 
bands were calculated and normalized with respect to background by using GelAnalyzer 2010 software.
Bioinformatics analysis of the miRNA target
To identify potential target sequences in the 3’UTR of retinoid receptor mRNA, various public database 
websites were utilized: miRNA.org (http://www.microrna.org/microrna/getGeneForm.do), miRDB (http://
www.mirdb.org/miRDB/) and TargetScanHuman (http://www.targetscan.org/vert_71/). For miRDB, 
miRNA target prediction program is based on support vector machines (SVMs), CLIP-ligation studies, a large 
microarray training dataset and a set of functional miRNAs annotated by integrating computational analyses 
with literature mining [28-30]. For Targetscan, 14 features (e.g., site type, 3′-supplementary pairing, local 
AU content, and distance from the closest 3′-UTR end), two miRNA features (TA and SPS) were selected and 
combined to develop the context++ model of miRNA targeting efficacy [31]. PicTar is also a computational 
method base on nuclMap, optimal free energy, alignments of highly probable nuclei and established score 
system [32]. Specific complementary target sequences were recorded for all predicted targets. In addition, 
another public database (miRTarBase, http://mirtarbase.mbc.nctu.edu.tw/) of experimentally validated 
miRNA targets was utilized to combine with the information of already published data.
Statistical analysis
Statistical analyses were performed using either Statistical Package for the Social Sciences (IBM SPSS 
Statistic 24) software or GraphPad Prism 7 (GraphPad Software, Inc.) software. Values were presented as 
means±SEM. Different statistical tests, such as one-way ANOVA and Pearson’s correlation were utilized 
depending on specific data types, as indicated in the figures. Values were considered significantly different 
when p-values were less than 0.05.
Results
Prediction of retinoid receptor sequences targeted by miRNAs
In our previous study, we showed that the down-regulation of retinoid receptors in 
PDAC is negatively correlated with patient survival, which indicates that retinoid receptors 
could function as tumor suppressors [24]. To investigate whether retinoid receptor mRNAs 
are targeted by specific miRNAs, the first step is to predict the specific binding sites in the 
3’UTRs. For this purpose, we integrated the predictions from different databases (Targetscan, 
mirbase, Pictar and miRDB) to increase the probability of finding all potential miRNA targets. 
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As these predictive databases are based 
on different algorithms, the prediction 
of miRNA target sequences from a single 
database could result in high numbers of 
false positives. We used both the intersection 
or the union of miRNA targets predicted by 
the different algorithms. As the purpose of 
this research was to find the dysregulated 
miRNAs that can target retinoid receptors 
in PDAC, we first recruited dysregulated 
miRNAs and then used different algorithms 
to predict potential candidate miRNAs that 
target retinoid receptors. If the selected 
miRNA was predicted to target any of these 
receptors by any of these algorithms, it was 
recruited for validation in the next step. To 
avoid missing any possible miRNA targets, 
we integrated the predictions from the 
different algorithms. Some of the miRNAs, 
like miR-27a and miR-27b, were predicted to target more than one retinoid receptor 
by more than one algorithm (Table 2). In 
the aggregate, miR-138, miR-206, miR-
613, miR-9, miR-27a/b and miR-613 can 
potentially target retinoid receptors.
To identify the specific targeted sites, 
each mRNA of the retinoid receptor was 
screened for complementarity to seed 
sequences of selected miRNAs. As a result, 
several 100% matches to target sequences were found: (1) miR-138 targets nt330-337 of 
the RARA-3’UTR; (2) miR-27a and miR-27b target nt740-747 of the RARA-3’UTR; (3) miR-
206 targets nt22-30 of the RARB-3’UTR; (4) miR-613 targets nt21-29 of the RARB-3’UTR; (5) 
miR-9-5p targets nt637-644 of the RXRA-3’UTR; (6) miR-27a/b-3p targets nt2818-2826 of 
the RXRA-3’UTR (Fig. 1). In addition, a partial match to a target sequence was also identified: 
miR-27a targets nt177-196 (data not shown).
Basal expression of selected miRNAs and retinoid receptors in PDAC cell lines compared to 
HPDE cells
To find out whether there are correlations between the expression of selected miRNAs 
and these retinoid receptors, we investigated the basal expression levels of miR-27a and 
b, -206, -613, -138, -9, -10a and b in a HPDE cell line and 4 PDAC cell lines: BxPC-3, Panc-
1, DanG, MiaPaCa-2. As one can see in Fig. 1, expression levels of these selected miRNAs 
varied considerably. Specifically, miR-27a increased by nearly 3 and 2 fold in BxPC-3 and 
MiaPaCa-2 cells respectively, compared to the expression level in HPDE cells. In contrast, the 
expression of miR-27a slightly decreases in PanC-1 and DanG cells (Fig. 2). Interestingly, the 
Table 2. Prediction of miRNA targets. aPredicted by 
miRNA.org and Targetscan, bPredicted by miRNA.org, 
Targetscan and miRDB, cPredicted by miRNA.org and 
miRDB, dPredicted by miRNA.org and miRDB, ePre-
dicted by Targetscan, fPredicted by Targetscan, gPre-
dicted by miRNA.org
 
 miR-9a miR-10 miR-27a/b miR-138 miR-206 miR-613 
RARα No No Yesa Yesb No No 
RARβ No No No No Yesc Yesd 
RXRα Yese No Yesf No No No 
RXRβ No No Yesg No No No    
Fig. 1. Target sequence of selected miRNAs within 
3’ UTR of retinoid receptors predicted by integrated database.Fig  1.  
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basal expression of miR-206, miR-613 and miR-138 are significantly decreased in PanC-1, 
DanG and MiaPaCa-2 cells, but not significantly changed in BxPC-3 cells compared to the 
level in HPDE cells. In addition, miR-9, miR-10a and miR-10b are all high expressed in PanC-
Fig. 2. miRNA expression in 
PDAC and HPDE cell lines de-
termined by RT-qPCR. 500 ng of 
total RNA extracted from each 
cell line was used to determine 
miRNA expression levels by 
RT-qPCR. Relative expression 
levels were calculated by nor-
malisation to the U6 expression 
level. An adjustment factor was 
applied to all miRNA relative expression levels so that the av-
erage value in HPDE cells was 
arbitrarily set to 1.0. The signifi-
cant fold changes of miRNA in 
PDAC cell lines compared with HPDE cells are indicated with an asterisk (*) or double asterisks (**) when 
p values are <0.05 or <0.01 respectively after performing one-way ANOVA. n.s. indicates that there is no 
significant difference between the indicated PDAC group and the HPDE group.
Fig. 2.  
Fig. 3. Messenger RNA expression of retinoid receptors in PDAC cell lines and HPDE cell line determined by 
RT-qPCR. 500 ng of total RNA extracted from each cell line was used to determine mRNA expression levels 
by RT-qPCR. Relative expression levels were calculated by normalization to the GAPDH expression level. 
An adjustment factor was applied to all miRNA relative expression levels so that the average value in HPDE 
was arbitrarily set to 1.0. The significant fold changes of mRNAs in PDAC cell lines compared with HPDE 
cells are indicated with double asterisks (**) when p values are <0.01 after performing one-way ANOVA. 
n.s. indicates that there is no significant difference between the indicated PDAC group and the HPDE group.
Fig. 3 
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1 cells.  For miR-27b, the expression levels increase significantly in BxPC-3 and PanC-1 cells 
with a fold change of 5 and 1.8 respectively, but decrease by 96% percent in MiaPaCa-2 cells 
(Fig. 2).
Table 3. Correlations between expression levels of 
selected miRNAs and retinoid receptors in HPDE 
and PDAC cell lines. a Spearman’s correlation coef-
ficient, b Spearman’s rank correlation test, *Signifi-
cantly correlated with Spearman’s correlation coef-
ficient > +0.50 or < −0.50 and P < 0.05
  RARα RARβ RXRα RXRβ 
miRNA27a -0.8a 0.104b +0.900* 0.037 +0.300 0.624 -0.600 0.285 
miRNA206 +0.100 0.873 +0.700 0.188 +0.900* 0.037 +0.300 0.624 
miRNA613 +0.500 0.391 +0.500 0.391 +0.900* 0.037 +0.700 0.188 
miRNA138 +0.300 0.624 +0.600 0.285 +1.000* 0.000 +0.400 0.505 
miRNA9 +0.700 0.188 -0.600 0.285 0.000 1.000 +0.600 0.285 
miRNA10a +0.051 0.935 -0.154 0.805 +0.154 0.805 -0.103 0.870 
miRNA10b -0.462 0.434 +0.359 0.553 +0.051 0.935 -0.308 0.614 
miRNA27b +0.000 1.000 +0.500 0.391 +0.700 0.188 +0.100 0.873  
Fig. 4. Expression of retinoid 
receptors in Panc-1 and DanG 
cells transfected with miR27a, 
miR27b or miR9. (A) RARα, 
(B) RARβ, (C) RXRα and (D) 
RXRβ. 25 μg of total protein 
extracted from Panc-1 and 
DanG cell lines were electro-
phoresed in 10% SDS-PAGE 
and followed by Western blot-
ting. The membrane was incu-
bated with rabbit polyclonal 
anti-RARa antibody as the pri-
mary antibody and IRDye® 
680CW Goat anti-Rabbit as 
the secondary antibody. GAP-
DH quantity was used as the 
loading control. Densitomet-
ric values of the bands were 
calculated and normalized against background using 
GelAnalyzer 2010 software. Relative intensities (i.e. den-
sity ratio of target protein/
GAPDH) are represented in 
bar diagrams, with each bar 
depicting the mean ± S.D. 
from 2 different analyses.
Fig. 4. 
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Next, we investigated the basal expression of RARα, RARβ, RXRα and RXRβ mRNAs in 
HPDE cells and PDAC cell lines. The results indicate that the expression of retinoid receptors 
varied in different cell lines: expression of RARα was significantly decreased in BxPC-3, PanC-
1 and MiaPaCa-2 cells, but increased in DanG cells (Fig. 3). Similarly, RARβ was significantly 
decreased in PanC-1, DanG and MiaPaCa-2 cells when compared to the level in the HPDE 
cells (Fig. 3). However, the expression of RARβ was more than 8 times higher in BxPC-3 cells 
compared to HPDE cells (Fig. 3). In PanC-1 and MiaPaCa-2 cells, RXRα expressions were 
significantly down-regulated compared to HPDE cells. RXRβ expressions are decreased in all 
four PDAC cell lines compared to the HPDE cell line (Fig. 3).
No obvious correlation between selected miRNAs and retinoid receptor expression
Based on the basal expression of selected miRNAs and retinoid receptors in PDAC cell 
lines and HPDE cells, we next wanted to find out whether the expression of selected miRNAs 
correlated with the gene expression level of retinoid receptors. For this purpose, Spearman’s 
rank correlation test was performed (Table 3). In HPDE cells and PDAC cell lines, expression 
levels of RARβ were positively correlated with the level of miR-27a. Furthermore, expression 
levels of RXRA were also shown to be positively correlated with miR-206, miR-613 and miR-
138. However, no other significant correlations between the selected miRNAs and retinoid 
receptors were observed.
Despite the positive or absent correlations between retinoid receptors and miRNA 
expressions, we next wanted to investigate the effect of miR-27a, miR27b and miR9 levels 
on the gene expression of retinoid receptors due to the following facts: (1) the expression 
levels of miR-27a, miR27b, miR9, miR10a and miR10b in PDAC cell lines were significantly 
higher than that in HPDE cells; (2) The absolute expression levels of miR-27a, miR27b, miR9, 
miR10a and miR10b were not very low or even higher compared to U6 expression in PDAC 
cell lines and HPDE cells; (3) A real interaction between  miR-27a and 3’UTP of RARA and 
RXRA has been demonstrated in rhabdomyosarcoma cells [33].
Transfection of PDAC cell lines with miR-27a, miR-27b and miR-9 does not influence 
retinoid receptor expression
To investigate the influence of miRNA on protein expression of the retinoid receptors, 
PDAC cells were transfected with miRNA mimics and incubated for 48 to 72 h under normal 
Fig. 5. Expression of MET in Panc-1 and DanG 
cells transfected with miR27a. (A) 25 μg total 
protein extracted from Panc-1 and DanG cell 
lines were electrophoresed in 10% SDS-PAGE 
and followed by Western blotting. The mem-
brane was incubated with rabbit polyclonal 
anti-MET antibody and mouse polyclonal anti-
GAPDH as primary antibodies and IRDye® 
680CW Goat anti-Rabbit and IRDye® 680CW 
Goat anti-Mouse as secondary antibodies. GAP-
DH quantity was used as the loading control; 
(B) Densitometric values of the bands were 
calculated and normalized against background 
using GelAnalyzer 2010 software. Relative in-
tensities (i.e. density ratio of target protein/
GAPDH) are represented in a bar diagram, with 
each bar depicting the mean ± S.D. from 2 dif-
ferent analyses.
  
Fig. 5. 
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conditions for cell culture. Whole protein contents were isolated and Western blot analyses 
were carried out as described in the Material and Methods. Western blot analysis revealed 
that after transfection of miR-9, miR-27a or miR-27b, there were no significant inhibitions 
of retinoid receptor expressions in both PanC-1 and DanG cells compared with a negative 
control (Fig. 4).
To be sure that no technical problems have occurred, MET - an experimentally validated 
target of miR27a, was selected as a positive control [34]. The same amount of miR27a was 
transfected into PanC-1 and DanG cells with the same procedure, as mentioned above. After 
incubation for 48 to 72 h under normal conditions, whole protein contents were isolated 
and Western blot analyses were carried out as described in the Material and Methods.  The 
analysis showed that transfection of miR27a mimics into PanC-1 and DanG cell lines led to a 
significant decrease in MET protein level (Fig. 5)
Transfection of miRNA inhibitors has no impact on retinoid receptor expressions
Finally, we investigated protein expression of retinoid receptors in PDAC cell lines after 
the transfection of miRNAs inhibitors. For this purpose, PDAC cells were transfected with 
Fig. 6. Expression of retinoid 
receptors in Panc-1 and DanG 
cells transfected with anti-
miR27a, anti-miR27b or anti-
miR9. (A) 20 μg total protein 
extracted from Panc-1 and 
DanG cell lines were electro-
phoresed in 10% SDS-PAGE 
and followed by Western blot-
ting. The membrane was incu-
bated with rabbit polyclonal 
antibody (anti-RARa, anti-
RARb, anti-RXRa or anti-RXRb) 
as the primary antibody and 
IRDye® 680CW Goat anti-Rab-
bit as the secondary antibody. 
GAPDH quantity was used as 
the loading control. (B) Ex-
pression of of various retinoid receptors depicted as relative 
intensities after the transfec-
tion of miRNA inhibitors. Den-
sitometric values of the bands 
were calculated and normal-
ized against background using 
GelAnalyzer 2010 software. 
Relative intensities (i.e. density 
ratio of target protein/GAPDH) are represented as bar dia-
grams, with each bar depicting 
the mean ± S.D. from 2 different 
analyses.
Fig. 6. 
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miRNA inhibitor and incubated for 48 to 72 h under normal conditions for cell culture. Whole 
protein contents were isolated and Western blot analyses were carried out, as described in 
the Material and Methods. The analyses revealed no significant changes in the expression 
of retinoid receptors in both PanC-1 cells and DanG cells compared with a negative control 
(Fig. 6).
Discussion
Consistent with our previous study, we showed in this report that retinoid receptors 
in PDAC cells are markedly down-regulated compared to normal pancreatic cells. The 
mechanisms by which retinoid receptors in cancer could be down-regulated include the 
following possibilities: (1) mutation or deletion of retinoid receptor genes; (2) transcriptional 
repression; (3) post-transcriptional repression. The fact that the retinoid receptor genes are 
not mutated in the majority of human cancer specimens indicates that epigenetic events 
could be involved. Studies have reported that RARβ can be repressed by hypermethylation 
and histone deacetylation in some types of cancer, resulting in an associated resistance to 
the growth inhibitory effects of retinoic acid in some cancer types [35-37].
Regulation of retinoid receptor genes on post-transcriptional level can also contribute 
to the dysregulated retinoid receptor expression in PDAC. Among these mechanisms, miRNA 
serves as a major pattern regulator of up to 30% of the protein-coding genes in mammals. 
Regulation by miRNAs result in the destabilization of target mRNA, translational repression 
and even activation [38].
In this study, we aimed to identify up-regulated miRNAs, which could target retinoid 
receptors in PDAC cell lines. We found that the selected up-regulated miRNAs (miR27a, 
miR27b and miR9) were not associated with the down-regulation of retinoid receptors. 
There were significant correlations between specific miRNA and retinoid receptors, such 
as the correlation between miR-613 and RXRA, but the correlation coefficient reveals that 
they are positively correlated rather than negatively correlated. As such, we cannot draw the 
conclusion that there are significant correlations that are meaningful for our experiments. 
Since a single miRNA has a lot of putative targets in a particular cell, we can assume that this 
pleotropic effect of miRNAs manifested in the modulation of expression of some proteins 
involved in the regulation of retinoid receptor expression.
However, the high expression of miR27, miR-21and miR-23a in PDAC patients was 
associated with aggressive tumor behavior and poor survival after PDAC resection. 
Specifically, miR-27a was found to target BTG2, ZBTB10 and Spry2, which are associated 
with cancer survival, growth and angiogenic responses in PDAC [39]. It was concluded 
that the triple combination of miR-21/23a/27a could be a prognosis factor of PDAC. These 
results showing that miR-27a is significantly up-regulated in PDAC cell lines are inconsistent 
with our results. Interestingly, Tombolan and his colleagues demonstrated that miR-27a is 
implicated in tumorigenesis as it targets RARα and RXRα expression in the 293T cell line 
[33]. A reason for this finding could be that specific miRNAs can have different effects in 
particular cell types and tumor entities.
Based on these findings, we conclude that miR-27a, miR-27b, miR-9, miR10a and miR-
10b are up-regulated in PDAC cells compared to HPDE cells. The up-regulation of these 
miRNAs is not responsible for the down-regulation of RARα, RARβ, RXRα and RXRβ in PDAC cells.
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